ICD-10 creates challenges for health plans who want to transition successfully from ICD-9 with respect to defining and redefining medical policy. This presentation addresses best practice approaches.
TGA Presentation: Medicines scheduling and scheduling policy ad hoc working g...TGA Australia
TGA Scheduling Working Group Meeting One February 2018. Role of the Working Group including Reforms to the advertising of S3 pharmacist only medicines, Reviewing what current S3 substances should be advertised, Proactively identifying S4 medicine substances for consideration for down-scheduling, Adding a new appendix to the poison standard to provide additional safeguards when down-scheduling
Quick Overview: Pharmaceutical Data IntegrityPeter Dellva
Brief overview of the most important aspects of pharmaceutical data integrity. Slideshare includes pharmaceutical and biopharmaceutical industry key resources.
Accelerating Post-approval Change Management with ICH Q12Veeva Systems
Adopting ICH Q12 and modern technologies can reduce the number of changes that require regulatory approval as well as accelerate evaluation, implementation, and global approval of a change. In a 2017 PDA survey, almost 40% of respondents said that 50% or more of their post-approval changes required submission to a health authority. With increasing complexity in the manufacturing of new therapies and growing number of changes that require filing review and updates in multiple markets, the global post-approval change management (PACM) process is becoming unmanageable.
Modern technologies are reducing complexity in pharma by bringing together systems and people to seamlessly support global, end-to-end processes. With greater visibility and collaboration, change management processes are more efficient and less risky. In this webinar, learn:
What is ICH Q12 and potential benefits
Best practices and approaches to key PACM challenges
Approaches to manage ‘established conditions’
How technology can support ICH Q12 and simplify change management
Innovative ways leading pharma companies are addressing PACM
TGA Presentation: Medicines scheduling and scheduling policy ad hoc working g...TGA Australia
TGA Scheduling Working Group Meeting One February 2018. Role of the Working Group including Reforms to the advertising of S3 pharmacist only medicines, Reviewing what current S3 substances should be advertised, Proactively identifying S4 medicine substances for consideration for down-scheduling, Adding a new appendix to the poison standard to provide additional safeguards when down-scheduling
Quick Overview: Pharmaceutical Data IntegrityPeter Dellva
Brief overview of the most important aspects of pharmaceutical data integrity. Slideshare includes pharmaceutical and biopharmaceutical industry key resources.
Accelerating Post-approval Change Management with ICH Q12Veeva Systems
Adopting ICH Q12 and modern technologies can reduce the number of changes that require regulatory approval as well as accelerate evaluation, implementation, and global approval of a change. In a 2017 PDA survey, almost 40% of respondents said that 50% or more of their post-approval changes required submission to a health authority. With increasing complexity in the manufacturing of new therapies and growing number of changes that require filing review and updates in multiple markets, the global post-approval change management (PACM) process is becoming unmanageable.
Modern technologies are reducing complexity in pharma by bringing together systems and people to seamlessly support global, end-to-end processes. With greater visibility and collaboration, change management processes are more efficient and less risky. In this webinar, learn:
What is ICH Q12 and potential benefits
Best practices and approaches to key PACM challenges
Approaches to manage ‘established conditions’
How technology can support ICH Q12 and simplify change management
Innovative ways leading pharma companies are addressing PACM
Bringing Legacy Combination Products into Compliance with 21 CFR Part 4Peter Dellva
Presentation provides an overview of 21 CFR Part 4 and discusses the approach to assure legacy combination drug products are compliant with the final rule.
FDA hosted three webinars after the release of the Food Safety Modernization Act (FSMA) Final Rules on Preventive Controls. These rules will set new safety requirements for facilities that manufacture, process, pack or hold human food and animal food.
Andwin Scientific specializes in Clinical Supplies and Equipment product manufacturing, sourcing, procurement, storage and distribution as a supplier to global life science organizations and a distributor to direct end using companies (including sites). This makes Andwin Scientific the only company that offers true consolidation for clinical studies by facilitating the purchase of products from various suppliers in one transaction.
Process Validation & Regulatory Strategies for Fast-track and Breakthrough Th...Peter Dellva
BioTechLogic's Tracy TreDenick delivered a compelling presentation discussing process validation & regulatory strategies for Fast-Track and Breakthrough Therapies at BPI West - March 20, 2018
Jan 31, 2018 How to Ensure Patient-Centred Pharmacare is Cost-Effective Healthcare A Consultation on Patented Medicine Prices Review Board & Biologic Medicines
CMS released the 2022 IPPS proposed rule and included changes to the hybrid measures and eCQMs. Most notably CMS added a brand-new hybrid measure to the mix which will be mandatory shortly!
Ben Quirk spoke to the South Florida medical group community about the impact of ICD-10 on the healthcare industry. It was a very informative talk that covered a lot of need-to-know details, including how ICD-10 relates to Meaningful Use and SNOMED.
Preparing for New FSMA Preventive Controls RegulationsAlchemy Systems
FDA's current deadline for publishing the final rules for preventative controls for is quickly approaching. Find out what your company needs to know to prepare for these new regulatory requirements for FDA-regulated processors. This presentation provides an overview of preventative controls requirements under the Food Safety Modernization Act (FSMA), what is HARPC, and how to make the HACCP to HARPC conversion, as well as reassessing food safety plans for compliance and effectiveness.
5 Critical Areas of Combination Drug CompliancePeter Dellva
This slideshare walks through five critical areas of combination drug compliance including: What is 21 CFR Part 4, FDA’s Office of Combination Products, Compliance for legacy combination products, Stability study strategy and more
FDA's current thinking on operational strategy for implementation work plans. Presentation from workshops held on April 23 ~ 24, 2015 at the Washington Marriott Hotel, DC.
Bringing Legacy Combination Products into Compliance with 21 CFR Part 4Peter Dellva
Presentation provides an overview of 21 CFR Part 4 and discusses the approach to assure legacy combination drug products are compliant with the final rule.
FDA hosted three webinars after the release of the Food Safety Modernization Act (FSMA) Final Rules on Preventive Controls. These rules will set new safety requirements for facilities that manufacture, process, pack or hold human food and animal food.
Andwin Scientific specializes in Clinical Supplies and Equipment product manufacturing, sourcing, procurement, storage and distribution as a supplier to global life science organizations and a distributor to direct end using companies (including sites). This makes Andwin Scientific the only company that offers true consolidation for clinical studies by facilitating the purchase of products from various suppliers in one transaction.
Process Validation & Regulatory Strategies for Fast-track and Breakthrough Th...Peter Dellva
BioTechLogic's Tracy TreDenick delivered a compelling presentation discussing process validation & regulatory strategies for Fast-Track and Breakthrough Therapies at BPI West - March 20, 2018
Jan 31, 2018 How to Ensure Patient-Centred Pharmacare is Cost-Effective Healthcare A Consultation on Patented Medicine Prices Review Board & Biologic Medicines
CMS released the 2022 IPPS proposed rule and included changes to the hybrid measures and eCQMs. Most notably CMS added a brand-new hybrid measure to the mix which will be mandatory shortly!
Ben Quirk spoke to the South Florida medical group community about the impact of ICD-10 on the healthcare industry. It was a very informative talk that covered a lot of need-to-know details, including how ICD-10 relates to Meaningful Use and SNOMED.
Preparing for New FSMA Preventive Controls RegulationsAlchemy Systems
FDA's current deadline for publishing the final rules for preventative controls for is quickly approaching. Find out what your company needs to know to prepare for these new regulatory requirements for FDA-regulated processors. This presentation provides an overview of preventative controls requirements under the Food Safety Modernization Act (FSMA), what is HARPC, and how to make the HACCP to HARPC conversion, as well as reassessing food safety plans for compliance and effectiveness.
5 Critical Areas of Combination Drug CompliancePeter Dellva
This slideshare walks through five critical areas of combination drug compliance including: What is 21 CFR Part 4, FDA’s Office of Combination Products, Compliance for legacy combination products, Stability study strategy and more
FDA's current thinking on operational strategy for implementation work plans. Presentation from workshops held on April 23 ~ 24, 2015 at the Washington Marriott Hotel, DC.
What makes ICD 10 codes different from ICD 9? Is it the code structure or there is more to this transition? Lets find out what makes ICD 10 stand out. See more at: http://vgnx.co/ICD9-vs-ICD10
Compliance alone will not deliver on ICD-10's potential to improve quality of care, reduce costs and elevate efficiency. Organizations need to find and apply meaning from the new code sets, which requires new IT infrastructure, partnerships and people.
Plan for Success Strategies to Align Reimbursement and Commercialization - OM...April Bright
Product launch is not the time to start securing reimbursement for your device. Reimbursement remains a complex process for orthopaedic companies that could be lessened if properly aligned throughout commercialization. Mr. Hunter shares the who, what and when of reimbursement to ensure that you’ve received proper coverage prior to launch.
The recent extension of the ICD-10 deadline was greeted with mixed reactions throughout the healthcare industry. Some favored an extension, while others preferred to move ahead with the change. In this webinar, we look at the pros and cons of the delay and how it will affect providers and patients. Reactions from other vendors are also presented.
Get Ready for Industry Wide Impact of ICD-10mckessonrms
Get ready for the widespread organizational change that will occur for healthcare providers and payors by ICD-10 conversion with this guide from McKesson Practice Consulting.
10 Steps to Prepare for ICD-10
These 10 steps will help you get ready
for the transition to the ICD-10 code
sets. You may want to forward this
to those in your organization who are
working on this initiative.
For more information visit http://sites.mckesson.com/practiceconsulting/
What is the status on ICD-10? In this Infographic I bring you the facts you always wanted to know & 6 foundation blocks for successful ICD-10 implementation
A McKesson Perspective for Physicians: ICD-10-CM/PCSrmsspeciality
Your health information management and medical billing systems are foundational to your revenue cycle and ICD-10 transition. Ensure these foundational systems are updated and fully tested. Learn more about the ICD-10 transition from McKesson.
A Study on Formulation of Costing SystemProjects Kart
A Study on Formulation of Costing System. Modern business needs frequent cost information about business activities to plan accurately for the future, to control business results and to make a proper appraisal of the performance of persons working in the organization. The fulfillment of these goals requires details about the costs incurred and benefits (revenues) obtained which are provided by “cost accounting”.
Financial accounting is developed over the time to record, summarize and present the financial transactions or events, which can be expressed in terms of money. This function was primarily concerned with record-keeping leading to preparation of Profit and Loss Account and Balance Sheet. The information obtained through financial accounts is useful to the shareholders, creditors, financial analysts, labour union, government authorities etc. However, the information generated by financial accountancy for several purposes is not sufficient for decision making in many areas.
Time and cost savings of using continua pw cJanna Guinen
This slide deck covers results from a survey conducted by PwC to determine time and cost savings associated with implementing Continua Health Alliance's Design Guidelines for end-to-end, plug-and-play interoperability in personal connected health ('anywhere, everywhere healthcare'). Surveys were conducted with several stakeholders in healthcare, such as: medical device manufacturer, payor, system integrator, provider
ICD-10 Implementation for Physicians WhitepaperMarie Bunch
Many providers are operating with blinders on, completely unaware of the magnitude of the conversion and potential train wreck ahead for their reimbursement. Support your physicians through the difficult change ahead by helping them take the right steps forward to make their transition as efficient and painless as possible.
Regardless of the size of the practice, training for any implementation – especially for one as complex and far reaching as ICD-10 – can be costly and difficult to deliver. With only a year remaining to complete the transition, providers and their staff must step up to planning, training, software/system upgrades/replacements, as well as other necessary investments. ICD-10 will require a significant education investment in order to ensure accurate coding and minimize productivity loss. While large organizations may have the resources to purchase training materials or send staff to training sessions, smaller organizations may have to depend on special societies or share resources to provide the needed training.
Start the conversation with your physicians now. Help them through the transition with resources designed to get them on board with the transition now. Practice Management Institute® (PMI) is already helping practices adapt to the change with classes especially focused on the transition steps for medical offices, hosted by leading hospitals across the country. PMI’s Professional Services Department and Faculty Team is committed to providing the most up-to-date information on implementation guidelines, coding conversion steps and staff training fulfillment.
About PMI
PMI is the nation’s leading provider of continuing education for medical office professionals, with a broad curriculum of educational workshops that address the office training needs for private practice physicians. Classes are presented in leading hospitals, health care systems, and medical societies. For more than 30 years, physicians have relied on PMI to provide the latest information on managing an efficient and compliant practice.
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...ssuserf63bd7
https://qidiantiku.com/solution-manual-for-horngrens-cost-accounting-a-managerial-emphasis-canadian-9th-edition-by-srikant-m-datar.shtml
Full download please contact u84757@protonmail.com or qidiantiku.com
Similar to Icd 10 and icd10 medical policy health plan under hipaa (20)
Employee Retirement Income Security Act (ERISA). Expert witness in the employee retirement income security act including administrative duties of plan sponsors and employers, administrative services only contracts, and third-party administrators. Over 60% of all American workers are employed by a self-funded or partially self-funded health insurance plan
ICD-10 for physicians: its about good patient care and clinical documentationMichael Arrigo
They key thing for physicians to know about ICD-10 is that if they are using good clinical documentation practices, the coders will do the hard work. Much of the burden of ICD-10 comes to those physicians who currently do not document the details of the patient condition. Those that do will feel less pain from the ICD-10 transition.
The number and type of new concepts required for ICD-10 are not foreign to clinicians. The focus of the documentation should really be about good patient care. Patients deserve to have accurate and complete documentation of their conditions.
If other industries understand the value of accurate and complete documentation of data about encounters, shouldn't healthcare?
ICD-10 reimbursement will introduce changes based on what was done and why. Certainly any physician interested providing good care cannot argue with this?
Many health care consulting vendors focus on technology issues surrounding ICD-10, but the organizational impact, skills, capabilities of your team are paramount. This presentation, originally given by Michael Arrigo, CEO of No World Borders focuses on an organizational strategy to implement ICD-10
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Icd 10 and icd10 medical policy health plan under hipaa
1. Health
Plan
ICD-‐10
Medical
Management
ICD-‐10
Medical
Policy
Remedia�on
Improvement
Opportuni�es
2. ICD-‐10
and
Medical
Policy
Management
1. Guiding
principals
for
Care
Management
Improve
wellness,
cost
savings,
auto-‐adjudica�on,
etc.
– ICD-‐10
specificity
will
allow
rules
to
enhance
pre-‐auth
and
auto-‐
adjudica�on,
improve
accuracy
and
consistency
applying
policies
2. ICD-‐10
Educa�on
and
Awareness
3. Develop
Criteria
for
priori�za�on
of
Policies
to
remediate
– Base
on
precise
intent
and
services
4. Clearly
define
intent
of
policy
(codable)
– Requires
increased
$,
�me
for
policy
reviews,
expedited
approval
– lack
of
staff
could
slow
process
5. Configure
Claims
System
to
reflect
intent
6. Tes�ng
adjudica�on
results
– Mul�ple
scenarios
with
each
policy
7. Maintenance
of
Configura�ons
&
Rules
– Classify
each
code
as
Include,
exclude,
review
For
a
complete
copy
of
this
material
please
contact
ICD10@noworldborders.com
Note:
Material
developed
in
partnership
with
Health
Data
Consul�ng
h�p://www.healthdataconsul�ng.com
3. Measures
of
Success
Compare
adjudica�on
rates
pre
and
post
policy
implementa�on
Reduc�on
of
manual
pre-‐authoriza�on
Increased
%
of
�me
allocated
to
case
management
Poten�al
Nega�ve
–
Increased
Medical
Loss
Ra�o
For
a
complete
copy
of
this
material
please
contact
ICD10@noworldborders.com
Note:
Material
developed
in
partnership
with
Health
Data
Consul�ng
h�p://www.healthdataconsul�ng.com
4. Tools
&
Resources
Research & evaluate tools to manage policies
Resource for standard clinical policies
– Compare to existing policy templates: Aetna, Harvard
Pilgrim, etc. policies are available
Implement Policy à ICD-10 code reference tool
– Classify each code as Include, exclude, review
Chose policies that are best to implement
– Top 10, easy to implement and manage
– Frequently used
Potential - Outsource for development of policy
Develop Guide or Manual for Policy development.
For
a
complete
copy
of
this
material
please
contact
ICD10@noworldborders.com
Note:
Material
developed
in
partnership
with
Health
Data
Consul�ng
h�p://www.healthdataconsul�ng.com
5. 1.
Guiding
Principles
Determine
Guiding
Principals
(per
Health
Plan
State
law)
– Efficient, Economical delivery of
healthcare (title 49, Ch. 20 Utah
code)
– Mission – Trust vs. Competitive
payer
– Balanced policy to deliver both
appropriate care and cost effective
care
– Address both Clinical, Payment
and Operational policy in ICD-10
Benefit:
1) Incremental
–
Perm.
2) Clarity,
speeds
policy
development
process
3) Reduce
conflict,
reduce
re-‐work
Measure:
1) Did
we
complete?
For
a
complete
copy
of
this
material
please
contact
ICD10@noworldborders.com
Note:
Material
developed
in
partnership
with
Health
Data
Consul�ng
h�p://www.healthdataconsul�ng.com
6. 2.
ICD-‐10
Educa�on
/
Awareness
Deeper
understanding
of
code
set
and
structure
Role
based
ICD-‐10
Training
– Clinicians,
Dra�er
of
Policy,
Configurators,
Approvers,
Case
Managers,
decision
makers
– Claims
Adjusters,
Customer
Service,
IT
Intro
/
Overview
Terminology
differences
ICD-‐9
to
ICD-‐10
Coding
For
a
complete
copy
of
this
material
please
contact
ICD10@noworldborders.com
Note:
Material
developed
in
partnership
with
Health
Data
Consul�ng
h�p://www.healthdataconsul�ng.com
7. 3.
Policy
Priori�za�on
Criteria
Criteria
for
Priori�za�on
of
Policies
– High
dollar
(high
value)
cases
– High
volume
– Opportunity
for
automa�on
or
streamlining
process
– High
margins
for
providers
– Improve
downstream
processes
– Improve
outcomes
for
pa�ents
– Exis�ng
ICD-‐9
legacy
policies
Build
Inventory
of
exis�ng
policies
– 100
Opera�onal
policies
– 400
Clinical
policies
Build
Inventory
of
New
Policies
(ICD-‐10)
– Analysis
of
exis�ng
claims
u�liza�on
Apply
Criteria
for
priori�za�on
Benefit:
1) Binary
-‐
Temp
2) Focus
3) Scope
4) U�lize
resources
�mely
Measure:
1) Is
it
done
or
not?
2) Did
criteria
reduce
scope
for
remedia�on
3) Did
we
apply
criteria
to
Inventory?
For
a
complete
copy
of
this
material
please
contact
ICD10@noworldborders.com
Note:
Material
developed
in
partnership
with
Health
Data
Consul�ng
h�p://www.healthdataconsul�ng.com
8. 4.
Clearly
Define
Intent
of
Policy
Iden�fy
owner
responsible
for
dra�ing
policy
Define
policy
components
and
iden�fy
whether
clinical
or
payment/
opera�onal
– Include
Venn
diagram
to
show
shared
components
– Confirm
policy
format
– Clinical
valida�on
of
applicability
– Coding
Analyst,
tes�ng
of
configurability
– Coordinate
linked
policies
(clinical
&
opera�onal)
– Policy
dic�onary,
consistent
terminology
(reusable
across
policies)
Policy
governance
/
approval
Develop
best
prac�ces
for
policy
wri�ng
Benefit:
1) Incremental
downstream
2) Permanent
3) Reduced
�me
to
make
policies
Measure:
1) How
long
does
this
step
take?
(per
policy)
2) Track
Pre
vs.
Post
For
a
complete
copy
of
this
material
please
contact
ICD10@noworldborders.com
Note:
Material
developed
in
partnership
with
Health
Data
Consul�ng
h�p://www.healthdataconsul�ng.com
9. 5.
Configure
policy
to
reflect
Intent
Must
link
from
Policy
to
codes
– ICD-‐10
Diagnosis
– ICD-‐10
Procedure,
CPT,
HCPC
System
Configurator
training
Need
way
to
define
codes
in
System
– Services
in
ICD-‐10
– Procedures
in
ICD-‐10
Benefit:
1) Enable
use
of
policy
Measure:
1) Time/
resources
per
policy
2) Level
of
re-‐work
required
For
a
complete
copy
of
this
material
please
contact
ICD10@noworldborders.com
Note:
Material
developed
in
partnership
with
Health
Data
Consul�ng
h�p://www.healthdataconsul�ng.com
10. 6.
Tes�ng
Create
scenarios
test
intent
of
policy
under
ICD-‐10
– Owner
of
test
case
development
– Internal
test
cases
– External
test
cases
– Clinical
/
pre-‐authoriza�on
– Claims
payment
End-‐to-‐end
tes�ng
Benefit:
1) Avoid
business
disrup�on
2) Avoid
unintended
consequences
Measure:
1) Did
it
work?
2) Actual
match
expected?
For
a
complete
copy
of
this
material
please
contact
ICD10@noworldborders.com
Note:
Material
developed
in
partnership
with
Health
Data
Consul�ng
h�p://www.healthdataconsul�ng.com
11. 7.
Policy
Maintenance
Policy
documents
Table
storing
Policy
link
to
ICD-‐10
codes
– Classify
each
code
as
Include,
exclude,
review
Standard
ICD-‐10
code
tables
System
Configura�ons
&
Rules
For
a
complete
copy
of
this
material
please
contact
ICD10@noworldborders.com
Note:
Material
developed
in
partnership
with
Health
Data
Consul�ng
h�p://www.healthdataconsul�ng.com